Govt waives import duty on Remdesivir

Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......

3 lakh remdesivir to be produced daily in 15 days: Govt

The government plans to double the production of antiviral drug remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19.......

India to produce 850mn Sputnik doses annually: RDIF

The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency......

Sputnik V vaccine may be added to India's Covid armoury soon

‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease. Joining the long list of firms to launch its own......

Sensex ends below 24,000 on Asia meltdown, oil woes

The 30 share S&P BSE Sensex ended below 24,000 – first time since May 2014 to settle at 23,962.  In a yet another turbulent day, markets ended lower amid a sell-off in Asian stocks that......

Sensex ends in the red amid volatile trade; IT, auto, realty fall

The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,542.95.  Benchmark indices ended marginally lower, amid volatile trading session,......

Pharma in 2014: Deals worth billions and fines worth millions

Even as private firms were busy stitching merger and partnership deals, the government also remained active during the year working on a separate policy to promote and strengthen domestic......